(19)
(11) EP 3 589 284 A1

(12)

(43) Date of publication:
08.01.2020 Bulletin 2020/02

(21) Application number: 18760857.5

(22) Date of filing: 28.02.2018
(51) International Patent Classification (IPC): 
A61K 31/395(2006.01)
A61K 31/506(2006.01)
A61K 31/505(2006.01)
(86) International application number:
PCT/US2018/020335
(87) International publication number:
WO 2018/160774 (07.09.2018 Gazette 2018/36)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD TN

(30) Priority: 28.02.2017 US 201762464675 P
16.03.2017 US 201762472468 P

(71) Applicants:
  • The General Hospital Corporation
    Boston, Massachusetts 02114 (US)
  • Dana-Farber Cancer Institute, Inc.
    Boston, MA 02215 (US)

(72) Inventors:
  • MURAKAMI, Ryo
    Tokyo 112-0011 (JP)
  • FISHER, David, E.
    Newton, MA 02459 (US)
  • MUJAHID, Nisma
    Spencerport, NY 14559 (US)
  • GRAY, Nathanael, S.
    Boston, MA 02130 (US)
  • LIANG, Yanke
    Belmont, MA 02478 (US)
  • CHOI, Hwan Geun
    Chestnut Hill, MA 02467 (US)

(74) Representative: Crooks, Elizabeth Caroline et al
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) USES OF PYRIMIDOPYRIMIDINONES AS SIK INHIBITORS